Abstract |
Development of effective polymer-based nanocarriers for the successful application in cancer therapy still remains a great challenge in current research. In the present study we present a dendritic polyglycerol-based multifunctional drug immunoconjugate that specifically targets and kills cancer cell lines expressing epidermal growth factor receptor (EGFR). The nanocarrier was provided with a dendritic core as a multifunctional anchoring point, doxorubicin (Doxo) coupled through a pH-sensitive linker, a fluorescence marker, poly( ethylene glycol), as solubilizing and shielding moiety, and a scFv antibody conjugated through the SNAP-Tag technology. The study provides the proof of principle that SNAP-tag technology can be used to generate drug-carrying nanoparticles efficiently modified with single-chain antibodies to specifically target and destroy cancer cells.
|
Authors | Ahmad Fawzi Hussain, Harald Rune Krüger, Florian Kampmeier, Tim Weissbach, Kai Licha, Felix Kratz, Rainer Haag, Marcelo Calderón, Stefan Barth |
Journal | Biomacromolecules
(Biomacromolecules)
Vol. 14
Issue 8
Pg. 2510-20
(Aug 12 2013)
ISSN: 1526-4602 [Electronic] United States |
PMID | 23782069
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Dendrimers
- Recombinant Fusion Proteins
- Single-Chain Antibodies
- O(6)-benzylguanine
- Guanine
- Doxorubicin
- O(6)-Methylguanine-DNA Methyltransferase
|
Topics |
- Animals
- Antineoplastic Agents
(chemistry, pharmacology)
- CHO Cells
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Cricetinae
- Cricetulus
- Dendrimers
(chemistry, pharmacology)
- Doxorubicin
(analogs & derivatives, chemistry, pharmacology)
- Drug Delivery Systems
- Drug Screening Assays, Antitumor
- Guanine
(analogs & derivatives, chemistry)
- Humans
- O(6)-Methylguanine-DNA Methyltransferase
(chemistry)
- Protein Binding
- Recombinant Fusion Proteins
(chemistry)
- Single-Chain Antibodies
(chemistry)
|